About: http://webisa.webdatacommons.org/174992929

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Marketing authorization submissions for Zelboraf are currently under review by health authorities in Australia, India, Mexico and other countries worldwide.
http://www.w3.org/ns/prov#wasQuotedFrom	biospace.com